1 patient evaluation for Bortezomib-cyclophosphamide-dexamethasone (VCd or CyBorD)

Sep 3, 2015 (Started May 30, 2015)

  • Effectiveness
    Major (for multiple myeloma)
  • Side effects
    Moderate (peripheral neuropathy)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: Weekly

Jun 4, 2015 (Started May 30, 2015)

  • Effectiveness
    Major (for multiple myeloma)
  • Side effects
    Moderate (peripheral neuropathy)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: Weekly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Bortezomib-cyclophosphamide-dexamethasone (VCd or CyBorD)